Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the January 2025 issue of JCAD.

Dr. Del Rosso reviews some of the most impactful research developments and drug approvals seen by the dermatology world in 2024.

Dr. Del Rosso discusses warning signs of serious adverse events related to trimethoprim-sulfamethoxazole prescribed to patients with acne.

Dr. Song provides helpful clinical tips for treating patients with methotrexate. 

Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment.

Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice. 

Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the October 2024 issue of JCAD. 

Dr. Kircik discusses a recent FDA-approval of an IL-17 inhibitor that has demonstrated to be safe and effective in patients with psoriasis.

Dr. Del Rosso discusses how to provide the correct treatment for the various presentations of psoriasis along with the impact psoriatic arthritis can have on these patients.

Dr. Gelfand discusses how to treat patients with psoriasis in terms of cardiovascular risk. He encourages clinicians to educate their patients about these events and the potential side effects they present.